BERLIN—Bayer AG unveiled on Wednesday billions in new costs cuts to offset falling demand in agricultural products—the market on which it had made a huge bet with its acquisition of Monsanto.

The German chemicals and pharmaceuticals company said the coronavirus pandemic would hit its crop-science business harder than anticipated as prices for various crops fell, consumption of biofuel decreased and competition in the soy market intensified.



Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.